Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, ...
Merck & Co is on the brink of ... At the moment drugs like dexamethasone and Gilead Sciences' intravenous antiviral Veklury (remdesivir) can be used in hospitals to reduce mortality in severe ...
Seres Therapeutics' financial moves, potential drug developments, and investment appeal for speculative buyers in the biotech ...
Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...
(Reuters) -Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some patients with a form of lung cancer lived without their ...
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck and Eisai's Keytruda-Lenvima combo delivered a win in liver cancer.
Summit Therapeutics' ivonescimab shows improved efficacy over Merck's Keytruda in Phase III ... The Historic Significance of Improving on a Best-Selling Drug: Regeneron One of the largest ...
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a ...
2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy ...
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...
Health authorities have said that stockpiled Tamiflu should work well against H5N1. Some experts question that bet.
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...